Scientists from The University of Manchester have used stem cell gene therapy to treat a fatal genetic brain disease in mice for the first time.
The method was used to treat Sanfilippo – a fatal inherited condition which causes progressive dementia in children – but could also benefit several neurological, genetic diseases.
Researchers behind the study, published in the journal Molecular Therapy this month, are now hoping to bring a treatment to trial in patients within two years.
Sanfilippo, a currently untreatable mucopolysaccharide (MPS) disease, affects one in 89,000 children in the United Kingdom, with sufferers usually dying in their mid-twenties. It is caused by the lack of SGSH enzyme in the body which helps to breakdown and recycle long chain sugars, such as heparan sulphate (HS). Children with the condition build up and store excess HS throughout their body from birth which affects their brain and results in progressive dementia and hyperactivity, followed by losing the ability to walk and swallow.
Dr Brian Bigger, from the University of Manchester’s Institute of Human Development who led the research, said bone marrow transplants had been used to correct similar HS storage diseases, such as Hurler syndrome, by transplanting normal cells with the missing enzyme but the technique did not work with Sanfilippo disease. This is because monocytes, a type of white blood cell, from the bone marrow, did not produce enough enzyme to correct the levels in the brain.
Dr Bigger said: “To increase SGSH enzyme from bone marrow transplants, and to target it to the cells that traffic into the brain, we have developed a stem cell gene therapy which overproduces the SGSH enzyme specifically in bone marrow white blood cells.
“We have shown that mice treated by this method produce five times the normal SGSH enzyme levels in the bone marrow and 11 per cent of normal levels in the brain.
“The enzyme is taken up by affected brain cells and is enough to correct brain HS storage and neuro inflammation to near normal levels and completely corrects the hyperactive behaviour in mice with Sanfilippo.
“This is extremely exciting and could have huge implications for treatments. We now hope to work to a clinical trial in Manchester in 2015.”
The University of Manchester team is now manufacturing a vector – a tool commonly used by molecular biologists to deliver genetic material into cells – for use in humans and hope to use this in a clinical trial with patients at Central Manchester University Hospital NHS Foundation Trust by 2015.
The stem cell gene therapy approach was recently shown by Italian scientists to improve conditions in patients with a similar genetic disease affecting the brain called metachromatic leukodystrophy, with results published in the journal Science earlier this month.
Manchester scientists refined the vector used by the Italian scientists. “This approach has the potential to treat several neurological genetic diseases,” Dr Bigger added.
The Latest Bing News on:
Stem cell gene therapy
- CRISPR gene therapy for sickle cell disease approved by the FDAon April 12, 2021 at 8:34 am
Currently, the only cure is a stem cell transplant from a healthy donor, but in the newly-approved trial, scientists from the University of California will use CRISPR/Cas9 genome editing to replace ...
- Cell Therapy Market projected to reach US$ 12,563.23 million by 2027 and to grow at a CAGR of 7.2%on April 9, 2021 at 12:57 pm
Stem cell therapies are being used to treat chronic diseases ... growing research on developing effective treatments for the disease is positively affecting the market growth. Gene therapy and cell ...
- Insights on the Gene Therapy Cell Culture Media Global Market to 2027 - Growth in Awareness Regarding Gene Therapy is Driving Growthon April 9, 2021 at 12:00 pm
The "Gene Therapy Cell Culture Media Market by Media Type, Viral Vectors Type and End User: Global Opportunity Analysis and Industry ...
- Sickle cell disease: scientists are developing a game-changing treatmenton April 9, 2021 at 3:01 am
While other treatments are aimed at the symptoms of sickle cell disease, a new revolutionary drug may target its root.
- Toward a reliable oral treatment for sickle cell diseaseon April 8, 2021 at 9:00 pm
WASHINGTON, April 9, 2021 -- For the millions of people worldwide who have sickle cell disease, there are only a few treatment options, which include risky bone marrow transplants, gene therapy or ...
- MicroRNA treatment modulates osteogenic differentiation potential of mesenchymal stem cells derived from human chorion and placentaon April 7, 2021 at 9:44 am
Mesenchymal stem cells (MSCs) are important in regenerative medicine because of their potential for multi-differentiation. Bone marrow, chorion and placenta have all been suggested as potential ...
- Worldwide Gene Therapy Cell Culture Media Industry to 2027 - by Media Type, Viral Vectors Type and End-user - ResearchAndMarkets.comon April 7, 2021 at 5:48 am
Gene therapy cell culture media consists of important ... and storage of microorganisms and other cell types such as stem cells, mammalian, and other cell lines. Different culture media are ...
- UNC-affiliated startup develops treatment to advance gene therapieson April 6, 2021 at 4:43 pm
The company, known as RainBio, is developing a particular type of gene therapy to combat blindness in patients with Mucopolysaccharidosis type I.
- Ionizing radiation exposure of stem cell-derived chondrocytes affects their gene and microRNA expression profiles and cytokine productionon April 5, 2021 at 5:31 am
Human induced pluripotent stem cells (hiPSCs ... The general profiles of the whole gene expression in the cells at 1 h and 24 h post-treatment are presented in the volcano plots (Supplementary Fig. 1) ...
- Researchers devise more efficient, enduring CAR gene therapy to combat HIVon April 2, 2021 at 6:20 am
A UCLA research team has shown that using a truncated form of the CD4 molecule as part of a gene therapy to combat HIV yielded superior and longer-lasting results in mouse models than previous similar ...
The Latest Google Headlines on:
Stem cell gene therapy
The Latest Bing News on:
- Become a hero for a Midlands girl living with Sanfilippo syndrome Saturday at the Super Eliza 5K!on April 9, 2021 at 12:30 pm
Eliza O’Neill is a young girl living with Sanfilippo syndrome, a rare genetic metabolism disorder that can lead to problems in the brain and nervous system. Friday morning, the Sanfilippo Foundation, ...
- Healthbeat: Mask wearing may help allergieson April 8, 2021 at 11:24 am
The mowing happening in Frank Sanfilippo’s yard isn’t being done by the Kingston ... It's been 18 years since a new drug has been approved to treat Alzheimer's disease, but one such medication is ...
- 5 Small-Cap Biotech Stocks Trading Under $10 With Massive Upside Potentialon April 3, 2021 at 3:56 am
a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson’s disease (PD).
- Mom fights for research for rare genetic disease that mimicked autism in her sonon April 1, 2021 at 2:54 pm
The doctors, according to a KVUE-TV report, told Connor’s mom he has a rare genetic condition called Sanfilippo Syndrome, a metabolism disorder that leads to serious problems in the brain and ...
- Abeona Therapeutics Announces 2020 Financial Results and Recent Operational Progresson March 25, 2021 at 5:15 pm
“In 2020, Abeona advanced our three clinical programs toward bringing urgently needed treatments to patients with recessive dystrophic epidermolysis bullosa (RDEB) and Sanfilippo syndrome type A ...
- Abeona Therapeutics Announces 2020 Financial Results and Recent Operational Progresson March 24, 2021 at 1:09 pm
© 2021 Insider Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and ...
- Abeona Therapeutics Announces 2020 Financial Results and Recent Operational Progresson March 24, 2021 at 1:01 pm
Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced financial results for the fourth quarter and full year 2020, and provided an update on ...
- Childhood Alzheimer’s: Understanding This Rare Conditionon March 22, 2021 at 3:12 pm
When you hear the term “Childhood Alzheimer’s” you probably think of a form of Alzheimer’s disease that affects children. However, that’s not actually the case. Childhood Alzheimer’s ...